Elevated circulating cardiac troponin I in patients with cirrhosis

D Pateron1, P Beyne, T Laperche

  • 1Laboratoire d'Hémodynamique Splanchnique et de Biologie Vasculaire INSERM, Hôpital Beaujon, Clichy, France.

Insights

Patients with cirrhosis often have unexplained cardiac issues. This study found elevated cardiac troponin I in 32% of patients, indicating subclinical myocardial damage, particularly in alcoholic cirrhosis.

Area of Science:

  • Cardiology
  • Hepatology
  • Biochemistry

Background:

  • Cirrhosis patients can present with unexplained cardiac abnormalities.
  • Cardiac troponin I is a specific biomarker for myocardial injury.

Purpose of the Study:

  • To investigate cardiac troponin I levels in patients with cirrhosis and normal ECG.
  • To identify potential correlations between troponin I levels and cardiac function or cirrhosis severity.

Main Methods:

  • Evaluated 32 cirrhosis patients (22 alcoholic) with normal ECG.
  • Performed hemodynamic investigations and echocardiography for left ventricular function and mass.
  • Measured serum cardiac troponin I, creatine kinase MB mass, and myoglobin.

Main Results:

  • Elevated cardiac troponin I (32%) observed, while other markers remained normal.
  • Abnormal troponin I correlated with decreased stroke-volume index and left ventricular mass.
  • No relation found between troponin I and cirrhosis severity or portal hypertension.

Conclusions:

  • A high prevalence of elevated cardiac troponin I exists in cirrhosis patients, especially those with alcoholic cirrhosis.
  • Elevated troponin I suggests subclinical left ventricular myocardial damage.
  • Findings may relate to impaired left ventricular adaptation in cirrhosis and alcoholic cardiomyopathy.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...